Absence of simian virus 40 (SV40) DNA in lymphoma samples from Tasmania, Australia

Pathology

Volumn 37, Issue 2, 2005, Pages 157-159

  Sui, Lee Fan ^a   Williamson, Jan ^a   Lowenthal, Ray M ^a,b   Parker, Andrew J C ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

^b ROYAL HOBART HOSPITAL   (Australia)

Author keywords

DNA amplification; Non Hodgkin's lymphoma; Poliovirus vaccine; SV40

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; AUSTRALIA; CANCER INCIDENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DOT HYBRIDIZATION; FEMALE; HUMAN; LYMPH NODE; MALE; NONHODGKIN LYMPHOMA; POLYMERASE CHAIN REACTION; SIMIAN VIRUS 40;

EID: 17844376513     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020500058474     Document Type: Article

References (30)

1. Shivapurkar N, Harada K, Reddy J, et al. Presence of simian virus 40 DNA sequences in human lymphomas. Lancet 2002; 359: 851-2.
2. Vilchez RA, Madden CR, Kozinetz CA, et al. Association between simian virus 40 and non-Hodgkin lymphoma. Lancet 2002; 359: 817-23.
3. Butel JS, Lednicky JA. Cell and molecular biology of simian virus 40: implications for human infections and disease. J Natl Cancer Inst 1999; 91: 119-34.
4. Newman L, Venn A, Fryer J, et al. Cancer in Tasmania: Incidence and Mortality 1980 to 1999. Hobart: Menzies Research Institute.
5. Rizzo P, Carbone M, Fisher SG, et al. Simian virus 40 is present in most United States human mesotheliomas, but it is rarely present in non-Hodgkin's lymphoma. Chest 1999; 116: 470S-3S.
6. David H, Mendoza S, Konishi T, et al. Simian virus 40 is present in human lymphomas and normal blood. Cancer Lett 2001; 162: 57-64.
7. Martini F, Dolcetti R, Gloghini A, et al. Simian-virus-40 footprints in human lymphoproliferative disorders of HIV- and HIV+ patients. Int J Cancer 1998; 78: 669-74.
8. Capello D, Rossi D, Gaudino G, et al. Simian virus 40 infection in lymphoproliferative disorders. Lancet 2003; 361: 88-9.
9. Yazdi AS, Puchta U, Flaig MJ, et al. Lack of evidence for the presence of Simian virus 40 DNA in cutaneous lymphomas. J Invest Dermatol 2003; 121: 212-3.
10. Daibata M, Nemoto Y, Kamioka M, et al. Simian virus 40 in Japanese patients with lymphoproliferative disorders. Br J Haematol 2003; 121: 190-1.
11. MacKenzie J, Wilson KS, Perry J, et al. Association between simian virus 40 DNA and lymphoma in the United Kingdom. J Natl Cancer Inst 2003; 95: 1001-3.
12. Purtilo DT, Strobach RS, Okano M, et al. Epstein-Barr virus-associated lymphoproliferative disorders. Lab Invest 1992; 67: 5-23.
13. Uchiyama T. Human T cell leukemia virus type I (HTLV-I) and human diseases. Annu Rev Immunol 1997; 15: 15-37.
14. Schulz TF. KSHV/HHV8-associated lymphoproliferations in the AIDS setting. Eur J Cancer 2001; 37: 1217-26.
15. Strauchen JA, Hauser AD, Burstein D, et al. Body cavity-based malignant lymphoma containing Kaposi sarcoma-associated herpesvirus in an HIV-negative man with previous Kaposi sarcoma. Ann Intern Med 1996; 125: 822-5.
16. Dolcetti R, Martini F, Quaia M, et al. Simian virus 40 sequences in human lymphoblastoid B-cell lines. J Virol 2003; 77: 1595-7.
17. Shah K, Nathanson N. Human exposure to SV40: review and comment. Am J Epidemiol 1976; 103: 1-12.
18. Strickler HD, Rosenberg PS, Devesa SS, et al. Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA 1998; 279: 292-5.
19. Engels EA, Katki HA, Nielsen NM, et al. Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40. J Natl Cancer Inst 2003; 95: 532-9.
20. Fraumeni JF Jr, Ederer F, Miller RW. An evaluation of the carcinogenicity of simian virus 40 in man. JAMA 1963; 185: 713-8.
21. Ferber D. Virology. Monkey virus link to cancer grows stronger. Science 2002; 296: 1012-5.
22. Malkin D. Simian virus 40 and non-Hodgkin lymphoma. Lancet 2002; 359: 812-3.
23. Klein G, Powers A, Croce C. Association of SV40 with human tumors. Oncogene 2002; 21: 1141-9.
24. McLaren BR, Haenel T, Stevenson S, et al. Simian virus (SV) 40 like sequences in cell lines and tumour biopsies from Australian malignant mesotheliomas. Aust N Z J Med 2000; 30: 450-6.
25. Mayall F, Barratt K, Shanks J. The detection of Simian virus 40 in mesotheliomas from New Zealand and England using real time FRET probe PCR protocols. J Clin Pathol 2003; 56: 728-30.
26. Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-8.
27. Bergsagel DJ, Finegold MJ, Butel JS, et al. DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N Engl J Med 1992; 326: 988-93.
28. Lednicky JA, Butel JS. Consideration of PCR methods for the detection of SV40 in tissue and DNA specimens. Dev Biol Stand 1998; 94: 155-64.
29. Lednicky JA, Garcea RL. Detection of SV40 DNA Sequences in Human Tissue. In: Raptis L, editor. SV40 Protocols. Totowa, NJ: Humana Press. 2000; 257-67.
30. Gluzman Y. SV40-transformed simian cells support the replication of early SV40 mutants. Cell 1981; 23: 175-82.